Home › Squamous Cell Carcinoma ng Esophagus › Virginia › Arlington

Pag-aaral pangklinika para sa Squamous Cell Carcinoma ng Esophagus sa Arlington, VA

14 pag-aaral para sa Squamous Cell Carcinoma ng Esophagus ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Arlington (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Nagre-recruitPhase 1

ALX Center 2, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT07085091

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Oncology Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277413

A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors

Nagre-recruitPhase 1/2

NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07730021

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Nagre-recruitPhase 1/2

NEXT Oncology, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07109726

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Nagre-recruitPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07217171

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Nagre-recruitPhase 3

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT06644781

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Nagre-recruitPhase 1

NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05208762

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Nagre-recruitPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT06657144

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Nagre-recruitPhase 1

Virginia Cancer Specialists, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 6, 2026 · NCT04389632

A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors

Nagre-recruitPhase 1/2

NEXT Oncology Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT06747585

Study of XB010 in Subjects With Solid Tumors

Nagre-recruitPhase 1

Inova Schar Cancer, Fairfax · 11 mi ang layo
NEXT Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 22, 2026 · NCT06545331

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Nagre-recruitPhase 1

NEXT Texas LLC - Virginia, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 18, 2026 · NCT07503808

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Nagre-recruitPhase 1

Research Site, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 12, 2026 · NCT07284186

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1/2

Research Site 102, Fairfax · 11 mi ang layo
Research Site 112, Fairfax · 11 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 21, 2025 · NCT05914116

Pag-aaral para sa Squamous Cell Carcinoma ng Esophagus sa ibang lungsod

Iba pang pag-aaral sa Arlington

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.